Phase I single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of BMS-927711 in healthy subjects

The Journal of Headache and Pain

Poster Presentation

D Burt¹  N Zheng¹  I Savant¹  R Bertz¹  N Jariwala¹  A Buzescu¹  G Tong¹  S Keswani¹ 

[1] Bristol-Myers Squibb, USA;

关键词: Placebo;    Migraine;    Calcitonin;    Multiple Dose;    Famotidine;   

DOI  :  10.1186/1129-2377-14-S1-P118

来源: Springer

【 授权许可】

Unknown   
© Tong et al; licensee Springer. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.